Damage-associated molecular patterns in tumor radiotherapy

被引:99
作者
Ashrafizadeh, Milad [1 ]
Farhood, Bagher [2 ]
Musa, Ahmed Eleojo [3 ]
Taeb, Shahram [4 ]
Najafi, Masoud [5 ]
机构
[1] Univ Tabriz, Fac Vet Med, Dept Basic Sci, Tabriz, Iran
[2] Kashan Univ Med Sci, Fac Paramed Sci, Dept Med Phys & Radiol, Kashan, Iran
[3] Univ Tehran Med Sci, Dept Med Phys, Int Campus, Tehran, Iran
[4] Shiraz Univ Med Sci, Ionizing & Nonionizing Radiat Protect Res Ctr INI, Shiraz, Iran
[5] Kermanshah Univ Med Sci, Sch Paramed Sci, Radiol & Nucl Med Dept, Kermanshah, Iran
关键词
Damage-associated molecular patterns (DAMPs); Radiotherapy; Tumor; Neoplasm; Adenosine; Immunotherapy; DENDRITIC CELLS; DNA-DAMAGE; ANTICANCER CHEMOTHERAPY; ATP RELEASE; CANCER; MICROENVIRONMENT; DEATH; INHIBITION; COMBINATION; INFUSIONS;
D O I
10.1016/j.intimp.2020.106761
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Radiotherapy is one of the most common modalities for the treatment of cancer. One of the most promising effects of radiotherapy is immunologic cell death and the release of danger alarms, which are known as damage-associated molecular patterns (DAMPs). DAMPs are able to trigger cancer cells and other cells within tumor microenvironment (TME), either for suppression or promotion of tumor growth. Heat shock proteins (HSPs) including HSP70 and HSP90, high mobility group box 1 (HMGB1), and adenosine triphosphate (ATP) and its metabolites such as adenosine are the most common danger alarms that are released after radiotherapy-induced immunologic cell death. Some DAMPs including adenosine is able to interact with both cancer cells as well as other cells in TME to promote tumor growth and resistance to radiotherapy. However, others are able to trigger anti-tumor immunity or both tumor suppressive and immunosuppressive mechanisms depending on affected cells. In this review, we explain the mechanisms behind the release of radiation-induced DAMPs, and its consequences on cells within tumor. Targeting of these mechanisms may be in favor of tumor control in combination with radiotherapy and radioimmunotherapy.
引用
收藏
页数:9
相关论文
共 96 条
[1]   The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Criollo, Alfredo ;
Ortiz, Carla ;
Lidereau, Rosette ;
Mariette, Christophe ;
Chaput, Nathalie ;
Mira, Jean-Paul ;
Delaloge, Suzette ;
Andre, Fabrice ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
IMMUNOLOGICAL REVIEWS, 2007, 220 :47-59
[2]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[3]   Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer [J].
Araujo, Jhajaira M. ;
Gomez, Andrea C. ;
Aguilar, Alfredo ;
Salgado, Roberto ;
Balko, Justin M. ;
Bravo, Leny ;
Doimi, Franco ;
Bretel, Denisse ;
Morante, Zaida ;
Flores, Claudio ;
Gomez, Henry L. ;
Pinto, Joseph A. .
SCIENTIFIC REPORTS, 2018, 8
[4]   PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer? [J].
Ashrafizadeh, Milad ;
Zarrabi, Ali ;
Samarghandian, Saeed ;
Najafi, Masoud .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 881
[5]   Abscopal effect in radioimmunotherapy [J].
Ashrafizadeh, Milad ;
Farhood, Bagher ;
Musa, Ahmed Eleojo ;
Taeb, Shahram ;
Rezaeyan, Abolhassan ;
Najafi, Masoud .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 85
[6]   How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? [J].
Aubrey, Brandon J. ;
Kelly, Gemma L. ;
Janic, Ana ;
Herold, Marco J. ;
Strasser, Andreas .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (01) :104-113
[7]   Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity [J].
Aymeric, Laetitia ;
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Martins, Isabelle ;
Kroemer, Guido ;
Smyth, Mark J. ;
Zitvogel, Laurence .
CANCER RESEARCH, 2010, 70 (03) :855-858
[8]   Treatment adherence and patients' acceptance of home infusions with adenosine 5'-triphosphate (ATP) in palliative home care [J].
Beijer, Sandra ;
Wijckmans, Nicole E. G. ;
van Rossum, Erik ;
Spreeuwenberg, Cor ;
Winkens, Ron A. G. ;
Ars, Lisette ;
Dagnelie, Pieter C. .
SUPPORTIVE CARE IN CANCER, 2008, 16 (12) :1419-1424
[9]   Effect of adenosine 5′-triphosphate infusions on the nutritional status and survival of preterminal cancer patients [J].
Beijer, Sandra ;
Hupperets, Pierre S. ;
van den Borne, Ben E. ;
Eussen, Simone R. ;
van Henten, Arjen M. ;
van den Beuken-van Everdingen, Marieke ;
de Graeff, Alexander ;
Ambergen, Ton A. ;
van den Brandt, Piet A. ;
Dagnelie, Pieter C. .
ANTI-CANCER DRUGS, 2009, 20 (07) :625-633
[10]   ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment [J].
Bianchi, G. ;
Vuerich, M. ;
Pellegatti, P. ;
Marimpietri, D. ;
Emionite, L. ;
Marigo, I. ;
Bronte, V. ;
Di Virgilio, F. ;
Pistoia, V. ;
Raffaghello, L. .
CELL DEATH & DISEASE, 2014, 5 :e1135-e1135